ECO 2026
12 - 15 May 2026
Renal or Hepatic Impairment Does Not Affect the Pharmacokinetics, Safety or Tolerability of Subcutaneous Cagrilintide
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.